LobbyingGenevant Sciences lobbying by quarter
Genevant Sciences's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $30K. Its first report covers Q1 2023; the issues it reports most are Health Issues and Copyright/Patent/Trademark.
Genevant Sciences
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $30K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $20K | 1 |
| Q2 2023 | $80K | 2 |
| Q3 2023 | $60K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $60K | 1 |
| Q2 2024 | $60K | 1 |
| Q3 2024 | $60K | 1 |
| Q4 2024 | $60K | 1 |
| Q1 2025 | $60K | 1 |
| Q2 2025 | $40K | 1 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$560K · 11 reports
- Copyright, patent and trademark$30K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES12 reports
- SENATE12 reports
Firms it paid
| Firm | ||
|---|---|---|
| Novel Strategies Prism Group | $530K | 10 quarters |
| S-3 Group | $60K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BAYLEE FINGERHUT | n/a | Q2 2026 |
| EDWARD B STEWART | n/a | Q2 2026 |
| JOHN GUY | n/a | Q2 2026 |
| JAY BRETT PERRON | n/a | Q2 2025 |
| JOHN STANFORD | n/a | Q2 2024 |
| KATE DICKENS | Chief of Staff, US Sen Mark Kirk; Leg Director, Rep Mike Castle; Foreign Policy Adv, Rep. Connie Morella | Q2 2023 |
| MARTIN REISER | Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee | Q2 2023 |
| MICHAELEEN EARLE CROWELL | Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders | Q2 2023 |
| OLIVIA KURTZ | Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/05for Q2 | Novel Strategies Prism Group | $30K |
| 08/04for Q2 | Novel Strategies Prism Group | Under $5,000 |
| 07/20for Q2 | Novel Strategies Prism Group | Under $5,000 |
| 25/07/17for Q2 2025 | Novel Strategies Prism Group | $40K |
| 25/04/18for Q1 2025 | Novel Strategies Prism Group | $60K |
| 25/01/17for Q4 2024 | Novel Strategies Prism Group | $60K |
| 24/10/18for Q3 2024 | Novel Strategies Prism Group | $60K |
| 24/07/17for Q2 2024 | Novel Strategies Prism Group | $60K |
| 24/04/18for Q1 2024 | Novel Strategies Prism Group | $60K |
| 24/01/22for Q4 2023 | Novel Strategies Prism Group | $60K |
| 24/01/05for Q2 2023 | Novel Strategies Prism Group | $40K |
| 23/10/12for Q3 2023 | Novel Strategies Prism Group | $60K |
| 23/07/20for Q2 2023 | S-3 Group | $40K |
| 23/06/23for Q2 2023 | Novel Strategies Prism Group | Under $5,000 |
| 23/04/20for Q1 2023 | S-3 Group | $20K |
| 23/03/31for Q1 2023 | S-3 Group | Under $5,000 |